Showing 35,658 results

Access to healthcare

The consequences of fear

News
1 November 2008
How HIV works

Can we create ‘elite controllers’?

News
1 November 2008

TB news from the World Lung Health Conference, Paris

News
31 October 2008
Drug-resistant TB

Migrants with MDR-TB in southern Africa being dumped off at borders without referrals to care

News
31 October 2008
TB transmission & prevention

More delays in the fight against TB in South Africa

News
31 October 2008
Testing & health monitoring

Enhanced Trofile assay better at identifying HIV tropisms, only slight impact on virologic outcomes

News
31 October 2008
TB treatment

Long hospital stays for TB treatment can increase risk of reinfection with MDR or XDR-TB strains

News
31 October 2008
TB diagnosis

South Africa’s lop-sided TB response: more attention to prevention of drug resistance required

News
31 October 2008
TB treatment

Plasma concentrations of rifampicin may be too low in children using currently recommended doses

News
31 October 2008
Health problems & ageing

High rate of MRSA recurrence in patients with HIV

News
31 October 2008
TB epidemiology

The scale of the challenge in fight against TB in South Africa

News
31 October 2008
Transmission & prevention

Superinfection seen frequently in heterosexual couples in Zambia

News
30 October 2008
People with limited treatment options

Once-daily darunavir/ritonavir may be an option for some treatment-experienced patients

News
30 October 2008
New & experimental HIV treatments

Darunavir European license extended to all treatment-experienced

News
30 October 2008
Starting treatment

Tenofovir/FTC more effective than abacavir/3TC in first-line boosted-PI regimens: meta-analysis

News
29 October 2008
Epidemiology

Initial CD4 cell counts in new seroconverters have declined over time

News
29 October 2008

HIV Weekly - 29th October 2008

October 2008
New & experimental HIV treatments

Vicriviroc: long-term safety concerns over cancers dispelled

News
28 October 2008
Resistance

Raltegravir resistance patterns becoming clearer

News
28 October 2008
Treatment interruptions

Continued antiretroviral therapy reduces bone mineral density in SMART study

News
27 October 2008
Starting treatment

No significant differences between elvucitabine and 3TC at 48 weeks

News
27 October 2008
New & experimental HIV treatments

Darunavir effective and tolerable in treatment-experienced children and adolescents at 48 weeks

News
27 October 2008
Starting treatment

Raltegravir non-inferior to efavirenz: 48 week, phase III results

News
27 October 2008
Starting treatment

Start treatment at CD4 cell counts below 500, says large cohort study

News
27 October 2008